NCT04978844

Brief Summary

The study will comprise of three groups of children (n=40): 1. A group receiving a novel short-term dynamic play therapy. 2. Dyadic therapy 3. Control group who will not receive therapy. All children will be assessed for psychopathology (anxiety, depression and behavioral problems) using standardized instruments such as semi-structured interview and self-reported questionnaires; EEG recordings will be performed from child and parents in order to asses brain synchrony; Cortisol (CT), Dehydroepiandrosterone (DHEA), Oxytocin (OT) and Secretory Immunoglobulin A (SIgA) will be assessed by using saliva sampling; and father-mother-child interactions will be videotaped and analyzed. Narrative descriptions will be obtained from parents, and the interviews recorded for voice analysis. Assessment will be made at baseline and then bi-monthly for six months.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2021

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

July 17, 2021

Completed
10 days until next milestone

First Posted

Study publicly available on registry

July 27, 2021

Completed
4.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2026

Completed
Last Updated

April 2, 2024

Status Verified

March 1, 2024

Enrollment Period

5 years

First QC Date

July 17, 2021

Last Update Submit

March 30, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Symptom change as measured by the CBCL

    The CBCL measures symptoms of psychopathology in a quantitive manner. Reduction in the number symptoms means a favorable outcome.

    Every two months for a period of six months

  • Maternal Sensitivity as measured with the CIB (coding interactional behavior)

    This measure is a video of mother-child interactions, a higher score is a more favorable outcome. scores range from a minimum of 0 to a maximum of 5.

    Every two months for a period of six months

Study Arms (3)

I-WotCH

ACTIVE COMPARATOR

I-WotCH- Inner World of the Child- is a novel innovative therapy developed in our clinic. The therapy is based on modern concepts of early childhood developments emphasizing themes related to emotional regulation, processes of socialization, observational research on interpersonal and behavior as well as recent developments on affiliative neuroscience. More specifically, the therapist, through play, identifies themes and emotions the child is preoccupied with. The therapist then assists the child in naming these emotions, validating them, exploring their nature and consequences. The therapists discussed ways of managing and self-regulating these emotions. These methods would include behavioral techniques, the ability to enlist help from others and reframing. In addition, the therapy will address dealing with complexed emotions and enhancing symbolic play and joyfulness.

Behavioral: IWOTCH

Dyadic therapy

ACTIVE COMPARATOR

Child parent psychotherapy: CPP consists of joint parent-child sessions that focus on the child's free play and spontaneous parent-child interaction. The CPP therapist acts to "translate" the developmental and emotional meaning of a child's emotions and actions to the parent. The target of treatment includes the both the child's and the caregiver's adaptive conflicts, including a parent's difficulty in providing sensitive and developmentally appropriate care. CPP fosters parent-child activities that foster mutual pleasure, interpersonal trust and understanding. In the purpose of this study only mothers will be included.

Behavioral: Dyadic therapy

Control

NO INTERVENTION

Healthy control.

Interventions

IWOTCHBEHAVIORAL

Arm 1

I-WotCH
Dyadic therapyBEHAVIORAL

Arm 2

Dyadic therapy

Eligibility Criteria

Age3 Years - 6 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • All consecutive admission to the early childhood clinic at the IDC Herzliya

You may not qualify if:

  • Parents and children not living in the same household

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Preschool clinic at the Interdisciplinary Center Herzlyia

Herzliya, Select A State Or Province, 4634601, Israel

RECRUITING

Study Officials

  • Feldman Ruth, Prof

    IDC Herzliya

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Yael Apter Levy, Phd

CONTACT

Maayan Greenberg, MA

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
outcome assessors: Post graduate students in clinical psychology, lab technicians
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: I-WotCH, Dyadic and Controls
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research psychologist

Study Record Dates

First Submitted

July 17, 2021

First Posted

July 27, 2021

Study Start

April 1, 2021

Primary Completion

April 1, 2026

Study Completion

April 1, 2026

Last Updated

April 2, 2024

Record last verified: 2024-03

Locations